Related Experiment Videos
Atheroembolic renal disease
S Saleem1, F G Lakkis, M Martínez-Maldonado
1Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.
Seminars in Nephrology
|July 1, 1996
Summary
Atheroembolic renal disease, caused by cholesterol crystal emboli, often underdiagnosed in the elderly, leads to kidney damage and systemic complications. Prompt diagnosis and supportive care are crucial due to lack of effective therapy.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Pathology
Background:
- Atheroembolic renal disease (AERD) is a significant cause of kidney insufficiency, particularly in elderly individuals.
- It arises from cholesterol crystal emboli originating from atherosclerotic plaques in major arteries, lodging in renal microvasculature.
- AERD is frequently underdiagnosed, contributing to progressive renal damage.
Purpose of the Study:
- To highlight the pathogenesis, clinical presentation, and diagnostic challenges of atheroembolic renal disease.
- To emphasize the systemic nature of cholesterol crystal embolization beyond the kidneys.
- To underscore the importance of early recognition and supportive management.
Main Methods:
- Review of clinical cases and literature on atheroembolic renal disease.
- Analysis of diagnostic criteria, including biopsy findings.
- Discussion of patient demographics and risk factors, such as vascular procedures.
Main Results:
- The typical patient is an older white male experiencing gradual serum creatinine elevation post-vascular procedures.
- Renal outcomes vary from partial recovery to end-stage renal disease.
- Systemic involvement affects skin, muscles, CNS, and abdominal organs, increasing morbidity and mortality.
Conclusions:
- Heightened clinical awareness is essential for timely diagnosis of AERD.
- Diagnosis is often confirmed via skin, muscle, or renal biopsy.
- While effective treatments are limited, supportive care is vital for managing this condition.